Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
Home
About Us
Management Team
Board of Directors
Products in Development
Intermezzo
®
TO-2061
Investors
Press Releases
Events & Presentations
Proxy Materials
SEC Filings
Corporate Governance
Management Team
Board of Directors
Committee Composition
Stock Information
Historic Stock Lookup
Analysts
Shareholder Tools
Shareholder Briefcase
Email Alerts
Careers
Contact
News & Events
Wednesday, December 21, 2011
Transcept Pharmaceuticals Receives $10 Million Milestone Payment from Purdue for Listing of Intermezzo Formulation Patents in FDA Orange Book
Thursday, December 8, 2011
Transcept Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
Wednesday, November 30, 2011
Transcept Pharmaceuticals to Host Conference Call to Discuss Purdue's Exercise of Option to Commercialize Intermezzo® in the United States
Wednesday, November 30, 2011
Transcept Pharmaceuticals Announces Purdue's Exercise of Option to Commercialize Intermezzo® in the United States
Transcept Stock Quote